Literature DB >> 12932863

Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy.

Koraljka Duric1, Snjezana Skrablin, Josko Lesin, Drzislav Kalafatic, Ivan Kuvacic, Ernest Suchanek.   

Abstract

OBJECTIVE: To assess the value of alpha-fetoprotein (AFP), total human chorionic gonadotropin (ThCG) and unconjugated estriol in predicting certain complications of pregnancy other than fetal aneuploidy. STUDY
DESIGN: Among 2384 women that underwent biochemical screening between 15 and 22 weeks of gestation, pregnancy outcome was evaluated in 677 women under 35 years of age according to serum marker levels by using cut-off points discriminative for Down syndrome or neural tube defect (NTD).
RESULTS: High alpha-fetoprotein levels (MoM>/=2.0) were found to be significantly more frequent (P<0.05) in cases of fetal growth restriction (odds ratio=2.7), miscarriage (odds ratio=4.4) and intrauterine fetal death (odds ratio=5.8). High chorionic gonadotropin levels (MoM>/=2.02) were associated with intrauterine growth restriction (odds ratio=2.1; P<0.05), miscarriage (odds ratio=4; P<0.01), preterm birth (odds ratio=2.5; P<0.05), and intrauterine fetal death (odds ratio=4.2; P<0.01). Among pregnancies with intrauterine growth restriction and threatening preterm delivery, low unconjugated estriol levels (MoM</=0.74) were significantly more frequent (odds ratio=2.2; P<0.05 and odds ratio=2.6; P<0.01, respectively).
CONCLUSION: All three markers predictive for fetal trisomy 21 shown to be associated with various pregnancy complications in euploid pregnancies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12932863     DOI: 10.1016/s0301-2115(03)00081-2

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  10 in total

1.  Extreme values of maternal serum analytes in second trimester screening: looking beyond trisomy and NTD's.

Authors:  Elizabeth McPherson; Ginger D Thomas; Christopher Manlick; Christina A Zaleski; Kara K Reynolds; Kristen Rasmussen; Philip F Giampietro; Carmen Wiley; Maria Mascola
Journal:  J Genet Couns       Date:  2011-04-20       Impact factor: 2.537

2.  Association Between Serum Markers Used in the Routine Prenatal Screening with Pregnancy Outcomes: A Cohort Study.

Authors:  Zohreh Alizadeh-Dibazari; Zahra Alizadeh-Ghodsi; Azita Fathnezhad-Kazemi
Journal:  J Obstet Gynaecol India       Date:  2021-08-06

3.  Automatic Time-Resolved Fluorescence Immunoassay of Serum Alpha Fetoprotein-L3 Variant via LCA Magnetic Cationic Polymeric Liposomes Improves the Diagnostic Accuracy of Liver Cancer.

Authors:  Kai Wang; Yuzhong Li; Xiaowei Wang; Jianpeng Jiao; Ying Li; Wenyue Gu; Xiaofei Liang
Journal:  Int J Nanomedicine       Date:  2020-07-10

4.  Maternal Serum Aneuploidy Screen and Adverse Pregnancy Outcomes.

Authors:  Koumudi Godbole; Aparna Kulkarni; Asawari Kanade; Shilpa Kulkarni; Girish Godbole; Anuradha Wakankar
Journal:  J Obstet Gynaecol India       Date:  2016-03-11

Review 5.  Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis.

Authors:  Rachel K Morris; Jeltsje S Cnossen; Marloes Langejans; Stephen C Robson; Jos Kleijnen; Gerben Ter Riet; Ben W Mol; Joris A M van der Post; Khalid S Khan
Journal:  BMC Pregnancy Childbirth       Date:  2008-08-04       Impact factor: 3.007

6.  Second trimester serum alpha-fetoprotein level is a significant positive predictor for intrauterine growth restriction in pregnant women with hyperemesis gravidarum.

Authors:  Enis Ozkaya; Evrim Cakır; Mehmet Cınar; Metin Altay; Orhan Gelişen; Fadıl Kara
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-12-01

7.  Investigating association between second trimester maternal serum biomarkers and pre-term delivery.

Authors:  Zahra Sehat; Azita Goshetasbi; Mehdi Taheri Amin
Journal:  Iran J Reprod Med       Date:  2013-02

8.  Association of high maternal blood alpha-fetoprotein level with risk of delivering small for gestational age: a meta-analysis.

Authors:  Eita Goto
Journal:  Pediatr Res       Date:  2020-09-12       Impact factor: 3.756

9.  Quad test for fetal aneuploidy screening as a predictor of small-for-gestational age fetuses: a population-based study.

Authors:  Rakchanok Boonpiam; Chanane Wanapirak; Supatra Sirichotiyakul; Ratanaporn Sekararithi; Kuntharee Traisrisilp; Theera Tongsong
Journal:  BMC Pregnancy Childbirth       Date:  2020-10-15       Impact factor: 3.007

10.  False-Positive Maternal Serum Screens in the Second Trimester as Markers of Placentally Mediated Complications Later in Pregnancy: A Systematic Review and Meta-Analysis.

Authors:  Christy L Pylypjuk; Joel Monarrez-Espino
Journal:  Dis Markers       Date:  2021-06-04       Impact factor: 3.434

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.